Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia

被引：0

作者：

Maribel Forero-Castro

Cristina Robledo

Rocío Benito

Irene Bodega-Mayor

Inmaculada Rapado

María Hernández-Sánchez

María Abáigar

Jesús Maria Hernández-Sánchez

Miguel Quijada-Álamo

José María Sánchez-Pina

Mónica Sala-Valdés

Fernanda Araujo-Silva

Alexander Kohlmann

José Luis Fuster

Maryam Arefi

Natalia de las Heras

Susana Riesco

Juan N Rodríguez

Lourdes Hermosín

Jordi Ribera

Mireia Camos Guijosa

Manuel Ramírez

Cristina Díaz de Heredia Rubio

Eva Barragán

Joaquín Martínez

José M Ribera

Elena Fernández-Ruiz

Jesús-María Hernández-Rivas

机构：

[1] IBSAL,Department of Hematology

[2] IBMCC,Department of Pediatric Oncohematology

[3] University of Salamanca,Department of Hematology

[4] CSIC,Department of Hematology

[5] Cancer Research Center,Department of Pediatrics

[6] Campus Miguel de Unamuno,Department of Hematology

[7] School of Biological Sciences (GICBUPTC research group),Department of Hematology

[8] Universidad Pedagógica y Tecnológica de Colombia (UPTC),Department of Hematology

[9] Avenida Central del Norte 39-115,Department of Hematology

[10] Molecular Biology Unit,undefined

[11] Hospital Universitario de La Princesa,undefined

[12] Instituto de Investigación Sanitaria Princesa (IIS-IP),undefined

[13] Calle Diego de León,undefined

[14] 62,undefined

[15] Hospital 12 de Octubre,undefined

[16] Avenida de Córdoba s/n,undefined

[17] Personalised Healthcare and Biomarkers,undefined

[18] Innovative Medicines and Early Development Biotech Unit,undefined

[19] AstraZeneca,undefined

[20] Hospital Universitario Virgen de la Arrixaca,undefined

[21] Ctra. Madrid-Cartagena,undefined

[22] s/n,undefined

[23] Hospital Río Carrión,undefined

[24] Av. Donantes de Sangre,undefined

[25] s/n,undefined

[26] Hospital Virgen Blanca,undefined

[27] Altos de Nava s/n,undefined

[28] Hospital Universitario de Salamanca,undefined

[29] Paseo de San Vicente,undefined

[30] 88-182,undefined

[31] Hospital Juan Ramón Jiménez,undefined

[32] Ronda Exterior Norte,undefined

[33] s/n,undefined

[34] Hospital de Jerez,undefined

[35] Carr Madrid-Cádiz,undefined

[36] ICO-Hospital Germans Trias i Pujol,undefined

[37] Instituto de Investigación Josep Carreras,undefined

[38] (Can Ruti),undefined

[39] Carretera de Canyet,undefined

[40] s/n,undefined

[41] Hematology Laboratory,undefined

[42] Institut de Recerca Pediátrica Hospital Sant Joan de Déu de Barcelona,undefined

[43] Passeig de Sant Joan de Déu,undefined

[44] 2,undefined

[45] Pediatric Oncohematology,undefined

[46] Hospital Universitario Infantil Niño Jesús,undefined

[47] Instituto de Investigación Sanitaria Princesa (IIS-IP),undefined

[48] Pediatric Oncohematology,undefined

[49] Hospital Vall d’Hebron,undefined

[50] Passeig de la Vall d'Hebron,undefined

来源：

British Journal of Cancer | 2017年 / 117卷

关键词：

acute lymphoblastic leukaemia (ALL); next-generation sequencing (NGS); prognosis; outcome; survival; mutation;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：256 / 265

页数：9

共 523 条

[1]

Bercovich D(2008)Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome Lancet 372 1484-1492

[2]

Ganmore I(2015)Biology of childhood acute lymphoblastic leukaemia Pediatr Clin North Am 62 47-60

[3]

Scott LM(2009)Integration of genomic and gene expression data of childhood ALL without known aberrations identifies subgroups with specific genetic hallmarks Genes Chromosomes Cancer 48 22-38

[4]

Wainreb G(2012)Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group study Blood 119 3512-3522

[5]

Birger Y(2016)CRLF2 overexpression identifies an unfavourable subgroup of adult B-cell precursor acute lymphoblastic leukemia lacking recurrent genetic abnormalities Leuk Res 41 36-42

[6]

Elimelech A(2013)TP53 mutations are frequent in adult acute lymphoblastic leukemia cases negative for recurrent fusion genes and correlate with poor response to induction therapy Haematologica 98 e59-e61

[7]

Shochat C(2014)Genomic characterization of acute leukemias Med Princ Pract 23 487-506

[8]

Cazzaniga G(2014)Diagnosis and subclassification of acute lymphoblastic leukemia Mediterr J Hematol Infect Dis 6 e2014073-e217

[9]

Biondi A(2011)Array comparative genomic hybridization and cytogenetic analysis in pediatric acute leukemias Curr Oncol 18 e210-3112

[10]

Basso G(1994)Clinical significance of p53 mutations in relapsed T-cell acute lymphoblastic leukemia Blood 84 3105-438

← 1 2 3 4 5 6 7 8 9 10 →